Article
Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
Kidney international - 1 Oct 2000
Covic A M, Schelling J R, Constantiner M, Iyengar S K, Sedor J R
Abstract excerpt
BACKGROUND: A homogeneous patient population is necessary to identify genetic factors that regulate complex disease pathogenesis. In this study, we evaluated clinical and biochemical phenotyping criteria for type 2 diabetes in end-stage renal disease (ESRD) probands of families in which nephropathy is clustered. C-peptide concentrations accurately discriminate type 1 from type 2 diabetic patients with normal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.